R115777 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2001

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

tipifarnib

Trial Locations (4)

91105

City of Hope Medical Group, Pasadena

95817

University of California Davis Cancer Center, Sacramento

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00025454 - R115777 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter